EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Broad neutralizing antibody response of a monomeric spike–based SARS-CoV-2 bivalent vaccine against diverse variants

Siling Wang iD, Hui Sun, Yizhen Wang, Zikang Wang, Lunzhi Yuan iD, Huilin Guo, Jiahua Gao, Miaolin Lan, Yangtao Wu, Huixian Shang, Xiuting Chen, Zheng Chen und 18 weitere

Proceedings of the National Academy of Sciences · 02.09.2025 · 122 (35)

DOI: 10.1073/pnas.2503254122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 25.08.2025. Verfasst von Siling Wang und 29 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen U…. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2) bivalent vaccines show potential against variants but lack a full understanding of the immunological mechanisms that drive broadly neutralizing antibodies (bnAbs). This study explored the immunogenicity of a bivalent vaccine in rhesus macaques, containing spike (S) proteins from the prototype (S prototype ) and chimeric S protein (S 1628x ). The vaccine induced bnAbs against multiple variants, including challenging subvariants like EG.1, BA.2.86, and JN.1. The monomeric S protein exposed less accessible regions within the receptor-binding domain (RBD) “inner face” and “NTD face” and subdomains 1, eliciting a diverse array of bnAbs against various Omicron subvariants. Notably, antibodies targeting the conserved RBD inner face, such as 4A5, showed potent neutralization across all tested variants. Structural analyses provide insights into the broad protectiveness of these vaccine-elicited nAbs. This study underscores the potential of bivalent vaccines with monomeric spike proteins to confer broad-spectrum immunity, offering a promising direction for future SARS-CoV-2 universal vaccine design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusSARS-CoV-2COVID-19 VaccinesCOVID-19Antibodies, ViralAntibodies, NeutralizingBroadly Neutralizing AntibodiesAnimalsMacaca mulattaHumans

Stichwörter der Autor:innen

SARS-CoV-2bivalent vaccinebroad neutralizing antibody

Substanzen

Spike Glycoprotein, CoronavirusCOVID-19 Vaccinesspike protein, SARS-CoV-2Antibodies, ViralAntibodies, NeutralizingBroadly Neutralizing Antibodies

Autor:innen und Institutionen

  • State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Life Sciences, School of Public Health, Xiamen University, Xiamen 361102, China.
  • National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research…
  • Department of Central Laboratory, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen 361102, China.
  • State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong 999077, China.
  • Joint Institute of Virology (Shantou University and University of Hong Kong), Guangdong-Hongkong Joint Laboratory of Emerging Infectious Diseases, Shantou University, Shantou 515063, China.
  • Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen 361102, China.

ORCID-Profile: Siling Wang, Lunzhi Yuan, Jinfu Su, Shaowei Li, Yi Guan, Ningshao Xia, Quan Yuan, Qingbing Zheng

Förderung

  • the National Key R&D Program of China

Zitieren

APA

Wang, S., Sun, H., Wang, Y., Wang, Z., Yuan, L., Guo, H., Gao, J., Lan, M., Wu, Y., Shang, H., Chen, X., Chen, Z., Hu, J., Tang, Z., Wen, G., Ying, D., Liu, C., Jiang, Y., Su, J., …, & Zheng, Z. (2025). Broad neutralizing antibody response of a monomeric spike–based SARS-CoV-2 bivalent vaccine against diverse variants. Proceedings of the National Academy of Sciences, 122(35). https://doi.org/10.1073/pnas.2503254122

Vancouver

Wang S, Sun H, Wang Y, Wang Z, Yuan L, Guo H, et al. Broad neutralizing antibody response of a monomeric spike–based SARS-CoV-2 bivalent vaccine against diverse variants. Proceedings of the National Academy of Sciences. 2025;122(35). doi:10.1073/pnas.2503254122

BibTeX
@article{Wang2025,
  author = {Wang, Siling and Sun, Hui and Wang, Yizhen and Wang, Zikang and Yuan, Lunzhi and Guo, Huilin and Gao, Jiahua and Lan, Miaolin and Wu, Yangtao and Shang, Huixian and Chen, Xiuting and Chen, Zheng and Hu, Jiayi and Tang, Zimin and Wen, Guiping and Ying, Dong and Liu, Chang and Jiang, Yanan and Su, Jinfu and Lin, Min and Wu, Ting and Li, Shaowei and Zhang, Tianying and Zhang, Jun and Guan, Yi and Xia, Ningshao and Yuan, Quan and Zheng, Qingbing and Zhang, Yali and Zheng, Zizheng},
  title = {Broad neutralizing antibody response of a monomeric spike–based SARS-CoV-2 bivalent vaccine against diverse variants},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {35},
  doi = {10.1073/pnas.2503254122}
}
Kostenlos starten →